SEC Form 4 · accession 0001104659-15-046994
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John W Cumming
Director
Period of report
Jun 19, 2015
Accepted (ET)
Jun 23, 2015 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $18.59 | Jun 19, 2015 | A | 17,647 | A | — | Jun 19, 2025 | Common Stock | 17,647 | 17,647 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 substantially equal monthly installments commencing June 19, 2015.